Loading
A phase 2 trial of encorafenib, cetuximab and bevacizumab (glioblastoma use) in colorectal cancer, run by Vall d'Hebron Institute of Oncology, now recruiting.
Combination Therapy for BRAF-V600E Metastatic CRCm is a phase 2, interventional study registered as NCT06411600 by Vall d'Hebron Institute of Oncology, with a registry enrolment figure of 94 participants, started 2024-05-17 and due to reach its primary completion in 2027-05-01. Interventions recorded: Encorafenib; Cetuximab; Bevacizumab. Conditions listed: Metastatic Colorectal Cancer. Primary outcome: Progression-Free Survival (PFS). Colorectal eligibility wording from the registry: "5 x ULN is allowed if direct (conjugated) ≤1". Sites: Spain. No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Bevacizumab (glioblastoma use), Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Bevacizumab (glioblastoma use), Cetuximab, Monoclonal antibodies, Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Encorafenib, Cetuximab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.
Shares Encorafenib, Bevacizumab (glioblastoma use), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/